Oscar Health (NYSE:OSCR) Shares Gap Up – Should You Buy?

Shares of Oscar Health, Inc. (NYSE:OSCR) gapped up prior to trading on Tuesday . The stock had previously closed at $14.26, but opened at $14.80. Oscar Health shares last traded at $14.62, with a volume of 5,284,593 shares trading hands.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on OSCR. Wall Street Zen raised Oscar Health from a “hold” rating to a “buy” rating in a research report on Saturday. Wells Fargo & Company cut shares of Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $18.50.

Oscar Health Trading Up 1.3%

The firm’s fifty day simple moving average is $13.74 and its 200-day simple moving average is $14.59. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market cap of $3.68 billion, a P/E ratio of -722.14 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same quarter in the previous year, the business earned $0.62 earnings per share. Oscar Health’s revenue for the quarter was up 42.2% on a year-over-year basis. Equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now owns 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 24.39% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Jones Financial Companies Lllp increased its holdings in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio bought a new stake in Oscar Health during the first quarter worth $30,000. Larson Financial Group LLC raised its position in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after buying an additional 2,512 shares during the last quarter. CWM LLC lifted its stake in Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after acquiring an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Oscar Health by 484.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock worth $45,000 after acquiring an additional 2,854 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.